Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Watanabe, Hirotoshi; Domei, Takenori; Morimoto, Takeshi; Natsuaki, Masahiro; Shiomi, Hiroki; Toyota, Toshiaki; Ohya, Masanobu; Suwa, Satoru; Takagi, Kensuke; Nanasato, Mamoru; Hata, Yoshiki; Yagi, Masahiro; Suematsu, Nobuhiro; Yokomatsu, Takafumi; Takamisawa, Itaru; Doi, Masayuki; Noda, Toshiyuki; Okayama, Hideki; Seino, Yoshitane; Tada, Tomohisa; Sakamoto, Hiroki; Hibi, Kiyoshi; Abe, Mitsuru; Kawai, Kazuya; Nakao, Kōichi; Andò, Kenji; Tanabe, Kengo; Ikari, Yuji; Igarashi Hanaoka, Keiichi; Morino, Yoshihiro; Kozuma, Ken; Kadota, Kazushige; Furukawa, Yutaka; Nakagawa, Yoshihisa; Kimura, Takeshi; the STOPDAPT-2 Investigators, for

doi:10.1001/jama.2019.8145

Public

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Published in JAMA • Jun 25, 2019

Authors:

Hirotoshi Watanabe

Takenori Domei

Takeshi Morimoto

Abstract

Importance: Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective: To test the hypothesis of noninferiority of 1 month of DAPT compared with standard 12 months of DAPT for a composite end ...

Subject

Medicine

Clopidogrel

Conventional PCI

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!